• TEXT SIZE

ENBREL Dosing for Moderate to Severe
Plaque Psoriasis

ENBREL is taken by injection and can fit easily into your schedule. Your doctor will tell you how often you should use ENBREL. Use ENBREL as prescribed.

Moderate to severe plaque psoriasis dosing

For the first 3 months of treatment, adult patients with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy are typically given 50 mg twice a week (3 or 4 days apart). After 3 months, a maintenance dose of 50 mg is given once per week. Some patients may experience a flare-up of symptoms of plaque psoriasis when beginning the reduced dose. In a medical study, approximately 95% of patients did not experience a flare-up when the dose was reduced. Be sure to follow your doctor's instructions.

Do NOT miss any doses of ENBREL. Call your doctor if you miss a dose of ENBREL. Your doctor will tell you if and when you should take your missed dose.

Injection site reactions such as redness, rash, swelling, itching, or bruising may occur. These symptoms usually go away within 3 to 5 days. If you experience these reactions and they don't go away or get worse, call your doctor.

Tip: Set aside specific times every week to prepare and take your injection of ENBREL. Do NOT use ENBREL more often than prescribed.

Please see Prescribing Information, Important Safety Information, and Medication Guide for complete details about ENBREL.


Need injection help?

Watch easy-to-follow videos and see how others self-inject ENBREL after receiving instructions from their healthcare provider.

Prescription ENBREL is taken by injection.

IMPORTANT SAFETY INFORMATION
Indication

Moderate to Severe Plaque Psoriasis
ENBREL is indicated for the treatment of adult patients (18 years or older) with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Supportive data
Moderate to Severe Plaque Psoriasis
  • In medical studies, nearly half of patients saw 75% skin clearance in 3 months. Overall, 3 out of 4 patients saw 50% skin clearance in 3 months.
10 years since FDA approval in moderate to severe plaque psoriasis
Diagnosed with plaque psoriasis?

Sign up today for more information about moderate to severe plaque psoriasis and ENBREL.

SIGN UP TODAY